Showing 1 - 8 results of 8 for search 'Jeffrey R Marks', query time: 0.03s Refine Results
  1. 1
    Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.

    Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. by Hsiu-Ni Kung, Jeffrey R Marks, Jen-Tsan Chi

    Published 2011-08-01
    Get full text
    Article
  2. 2
    Classification performance bias between training and test sets in a limited mammography dataset.

    Classification performance bias between training and test sets in a limited mammography dataset. by Rui Hou, Joseph Y Lo, Jeffrey R Marks, E Shelley Hwang, Lars J Grimm

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Classification performance bias between training and test sets in a limited mammography dataset

    Classification performance bias between training and test sets in a limited mammography dataset by Rui Hou, Joseph Y. Lo, Jeffrey R. Marks, E. Shelley Hwang, Lars J. Grimm

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ

    Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ by Faranak Sobhani, Sathya Muralidhar, Azam Hamidinekoo, Allison H. Hall, Lorraine M. King, Jeffrey R. Marks, Carlo Maley, Hugo M. Horlings, E. Shelley Hwang, Yinyin Yuan

    Published 2022-09-01
    Get full text
    Article
  5. 5
    Unmasking the immune microecology of ductal carcinoma in situ with deep learning

    Unmasking the immune microecology of ductal carcinoma in situ with deep learning by Priya Lakshmi Narayanan, Shan E. Ahmed Raza, Allison H. Hall, Jeffrey R. Marks, Lorraine King, Robert B. West, Lucia Hernandez, Naomi Guppy, Mitch Dowsett, Barry Gusterson, Carlo Maley, E. Shelley Hwang, Yinyin Yuan

    Published 2021-03-01
    Get full text
    Article
  6. 6
    Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance)

    Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance) by Jeffrey R. Marks, Dadong Zhang, Timothy Hardman, Yunn-yi Chen, Allison Hall, Lunden Simpson, Tina Hieken, Isabelle Bedrosian, Elissa Price, Jeff Sheng, Yanwan Dai, Marissa Lee, Alexander B. Sibley, Kouros Owzar, E. Shelley Hwang

    Published 2025-02-01
    Get full text
    Article
  7. 7
    Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility

    Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility by Stephen R Piccolo, Laura M Hoffman, Thomas Conner, Gajendra Shrestha, Adam L Cohen, Jeffrey R Marks, Leigh A Neumayer, Cori A Agarwal, Mary C Beckerle, Irene L Andrulis, Avrum E Spira, Philip J Moos, Saundra S Buys, William Evan Johnson, Andrea H Bild

    Published 2016-03-01
    Get full text
    Article
  8. 8
    Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome

    Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome by Siri H. Strand, Kathleen E. Houlahan, Vernal Branch, Thomas Lynch, Belén Rivero-Guitiérrez, Bryan Harmon, Fergus Couch, Kristalyn Gallagher, Mark Kilgore, Shi Wei, Angela DeMichele, Tari King, Priscilla McAuliffe, Christina Curtis, Kouros Owzar, Jeffrey R. Marks, Graham A. Colditz, E. Shelley Hwang, Robert B. West

    Published 2024-09-01
    Get full text
    Article

Search Tools: